NCT02243137View on ClinicalTrials.gov

Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Adverse Effect of Antithrombotic Drugs
Interventions
DRUG

acetylsalicylic acid

Administration: one dose of Acetylsalicylic Acid (300mg)

DRUG

prasugrel

Administration: one loading dose (60mg)

DRUG

lysine acetylsalicylate

Administration: one dose (450mg iv)

Trial Locations (1)

28040

Hospital Clínico San Carlos, Madrid

All Listed Sponsors
collaborator

St Carlos Hospital, Madrid, Spain

OTHER

lead

David Vivas

OTHER

NCT02243137 - Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate | Biotech Hunter | Biotech Hunter